Genetic diagnosis in IVF treatment in Cyprus is an advanced technology method that analyzes embryos for chromosomal and genetic health to ensure only healthy embryos are transferred. Dr. Murat Önal’s clinic applies PGT and PGS tests with the most modern genetic laboratory infrastructure, increasing pregnancy rates and the chance of healthy births.
Genetic tests provide great advantages, especially for couples with recurrent miscarriages, advanced maternal age, or carriers of genetic diseases.
Preimplantation Genetic Diagnosis (PGT) and Preimplantation Genetic Screening (PGS) are procedures where cells are biopsied from embryos during IVF treatment for genetic analysis.
PGT is a test performed to detect specific genetic diseases in embryos. For example, single-gene disorders such as thalassemia, cystic fibrosis, and SMA can be identified before transfer.
PGS is a test that screens embryos for numerical chromosomal abnormalities. Its aim is to identify conditions like Down syndrome and Turner syndrome to ensure healthy embryo transfer.
Note: PGT and PGS tests do not guarantee genetic health but significantly increase pregnancy chances and minimize genetic disease risks.
Genetik tanı süreci, tüp bebek tedavisi sırasında aşağıdaki adımlarla uygulanır:
1 – Ovarian Stimulation and Egg Retrieval
The woman undergoes ovarian stimulation, and mature eggs are collected.
2 – Fertilization (ICSI)
Retrieved eggs are fertilized with sperm in the lab to create embryos.
3 – Embryo Development
Embryos are cultured to day 5 (blastocyst stage).
4 – Embryo Biopsy
A few cells are biopsied from day 5 embryos. This does not harm the embryo.
5 – Genetic Analysis
Cells are sent to the genetic laboratory for PGT or PGS testing.
6 – Healthy Embryo Transfer
Genetically healthy embryos, and if desired, of the selected gender, are transferred to the patient.
Dr. Murat Önal collaborates with internationally accredited laboratories to perform all genetic diagnosis processes and provides detailed genetic counseling to his patients.
Genetic diagnosis tests are recommended for:
Dr. Murat Önal evaluates genetic diagnosis needs in detail during the initial consultation and determines the most appropriate test protocol.
The main genetic tests performed during IVF treatment in Cyprus include:
Analyzes the numerical structure of all chromosomes to detect abnormalities such as Down syndrome.
For carrier couples of single-gene diseases (e.g., cystic fibrosis, thalassemia, SMA), it prevents transfer of affected embryos.
Used to prevent embryos from inheriting structural chromosomal abnormalities such as translocations or inversions.
Dr. Murat Önal’s clinic offers the broadest genetic screening panels in cooperation with internationally accredited laboratories.
| Feature | PGT (Preimplantation Genetic Diagnosis) | PGS (Preimplantation Genetic Screening) |
| Purpose | Detect specific genetic diseases | Screen for chromosomal abnormalities |
| Usage | Carriers of genetic diseases | Advanced age, recurrent miscarriage, implantation failure |
| Analysis | Single gene analysis | Examines all 23 chromosome pairs |
| Gender Selection | Determined as a byproduct | Gender selection possible |
Result: Both tests evaluate embryo genetic health, but PGT focuses on diseases, while PGS focuses on chromosomal count.
The genetic diagnosis process in IVF treatment is meticulously carried out with modern laboratory infrastructure and an expert embryology team:
Cells are biopsied from day 5 embryos. This does not affect embryo development
Dr. Murat Önal follows each step closely to provide the most accurate genetic counseling to his patients.
Genetic diagnosis significantly increases IVF success rates because transferring chromosomally healthy embryos:
Increases pregnancy rates
Reduces miscarriage risks
PGT-A pregnancy rate: 65–80%
PGT-M and PGT-SR: Reduce the risk of transferring affected embryos to below 1%
Result: Genetic diagnosis not only improves pregnancy rates but also significantly increases healthy birth rates.
After genetic diagnosis, chromosomally healthy embryos are identified and prepared for transfer.
Advantage: Transferring genetically normal embryos increases pregnancy chances and reduces miscarriage risks.
Result: Genetic testing is the most advanced safety and success technology in IVF treatments.
For couples with recurrent miscarriages, genetic disease carriers, advanced maternal age, or recurrent IVF failures.
Cells are biopsied from day 5 embryos, analyzed in genetic labs, and results are ready in 5–10 days.
PGT-A tests: €2,500–€3,500, PGT-M tests: €3,500–€5,000.
Yes. Transferring genetically healthy embryos increases pregnancy and live birth rates.
Yes. Gender determination is possible during PGT and is legal in Cyprus.
No. Biopsy does not affect development when performed in experienced labs.
Results are typically available within 5–10 days.
No. Biopsy is done on embryos; no extra procedure is required for the patient.
Women over 35, those with recurrent miscarriages, or failed IVF attempts.
Single-gene diseases like thalassemia, SMA, cystic fibrosis; chromosomal abnormalities like Down syndrome.
Healthy embryos are prepared, and transfer is performed when the uterus lining is ready.
Between 65–80%.
Yes. Genetic testing is legal and regulated by the Ministry of Health in Cyprus.
Appointments can be made by filling out the online form on Dr. Murat Önal’s website or by calling the contact number.